Medicare AdvantageCoverageMedium impact
MA11.103c, Chemical Peels
Independence Blue Cross·Dermatology, Plastic Surgery, General Surgery·Medical Policy
Effective date
Dec 29, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross Medicare Advantage has expanded coverage for chemical peels treating actinic keratoses to be medically necessary without restrictions, effective 12/29/2025. Additionally, the ICD-10 code L57.9 has been removed from the policy. Billing teams must update systems to reflect unrestricted coverage for actinic keratosis treatment and ensure proper documentation is submitted with all chemical peel claims.
Action Required
By 12/29/2025: Billing team must update systems to remove any coverage restrictions or quantity limits for CPT 15789 and 15793 when billed with ICD-10 code L57.0 (actinic keratosis). Remove ICD-10 code L57.9 from any policy-related lookups or edits in billing software. Update claim submission templates to ensure required photographs are attached to all chemical peel requests per policy documentation requirements. Providers should be notified that actinic keratosis treatment via chemical peel is now covered without restrictions based on lesion or patient characteristics. Failure to submit required documentation (photographs) may result in claim denials despite medical necessity criteria being met.